AETHLON MEDICAL, INC. Letters of Credit Outstanding, Amount
AETHLON MEDICAL, INC. (AEMD) had Letters of Credit Outstanding, Amount of $87.51 thousand as of 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2026-02-12
- 2025-12-31: Letters of Credit Outstanding, Amount $87.51K.
- 2025-09-30: Letters of Credit Outstanding, Amount $87.51K.
- 2025-06-30: Letters of Credit Outstanding, Amount $87.51K.
- 2024-12-31: Letters of Credit Outstanding, Amount $87.51K.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2025-12-31 | $87.51K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $87.51K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $87.51K 10-Q · filed 2025-08-13 |
| 2024-12-31 | $87.51K 10-Q · filed 2025-02-12 |
| 2024-09-30 | $87.51K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $87.51K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $87.51K 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |